Brief: Nuvectis Pharma, Inc. Q2 EPS USD -0.38
09/08/2023 13:03
Aug 9 (Reuters) - Nuvectis Pharma, Inc. Q2 net income USD -5.708 million. * Q2 EPS USD -0.38
Recent news on Nuvectis Pharma
See all newsNuvectis Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Nuvectis Pharma Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: Ciprocopan (NXP100) Receives Marketing Approval In China For The Treatment Of Patients With PNH Previously Untreated With Complement Inhibitors
U.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin